The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Concordance between liquid and tissue biopsy in participants with newly diagnosed recurrent breast cancer.
 
Ana Elisa Lohmann
Honoraria - La Roche Posay; Novartis
Research Funding - Apotex (Inst); Epic Sciences (Inst); Novartis (Inst); Roche (Inst); Seagen (Inst)
 
Marguerite Ennis
No Relationships to Disclose
 
Pamela Jean Goodwin
Research Funding - Epic Sciences (Inst)
 
Zachary William Neil Veitch
Honoraria - AstraZeneca; Genomic Health; Gilead Sciences; Knight Pharmaceuticals; Novartis; Pfizer/EMD Serono
 
Christine Brezden
Honoraria - AstraZeneca; Gilead Sciences; Sanofi; Seagen
Consulting or Advisory Role - Agendia; Apobiologix; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Gilead Sciences; Knight Pharmaceuticals; Lilly O.; Merck; Mylan; Novartis; Pfizer; Roche; Sanofi; Seagen; Taiho Pharmaceutical
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Lilly O. (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Knight Pharmaceuticals
 
Katarzyna Joanna Jerzak
Honoraria - Amgen; Apobiologix; AstraZeneca; Eisai; Genomic Health; Gilead Sciences; Knight Therapeutics; Lilly; Merck; Myriad Genetics; Novartis; Pfizer; Roche; Seagen
Consulting or Advisory Role - Amgen; Apobiologix; AstraZeneca; Eisai; Genomic Health; Gilead Sciences; Knight Therapeutics; Lilly; Merck; Myriad Genetics; Novartis; Pfizer; Roche; Seagen; Seagen
Research Funding - AstraZeneca; Lilly; Seagen
Patents, Royalties, Other Intellectual Property - I am the lead inventor on a patent for the use of dronedarone and its structural derivatives as cancer therapies.
Other Relationship - Roche
 
Kathie Baer
No Relationships to Disclose
 
Samuel Martel
Consulting or Advisory Role - AstraZeneca; Knight Therapeutics; Novartis; Pfizer
 
Julie Lemieux
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Lilly; Merck; Novartis
Research Funding - Imagia
Patents, Royalties, Other Intellectual Property - Patent related to health. (I)
 
Jose Luiz Miranda Guimaraes
Travel, Accommodations, Expenses - Pfizer
 
David W. Cescon
Consulting or Advisory Role - AstraZeneca; Eisai; Gilead Sciences; GlaxoSmithKline; INFLEX; Lilly; Merck; Novartis; Pfizer; SAGA Diagnostics
Research Funding - AstraZeneca (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Inivata (Inst); Knight Therapeutics (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - Patent (US62/675,228) for methods of treating cancers characterized by a high expression level of spindle and kinetochore associated complex subunit 3 (ska3) gene.
Expert Testimony - AstraZeneca
(OPTIONAL) Uncompensated Relationships - Inivata
 
Michael P. Thirlwell
No Relationships to Disclose
 
Megan Slade
Employment - Epic Sciences
Travel, Accommodations, Expenses - Epic Sciences
 
Giuseppe Di Caro
Employment - Epic Sciences; Pfizer
Stock and Other Ownership Interests - Epic Sciences; Pfizer
Patents, Royalties, Other Intellectual Property - Pfizer
Travel, Accommodations, Expenses - Epic Sciences; Pfizer
 
Rick Wenstrup
Employment - Epic Sciences
Leadership - Epic Sciences
Stock and Other Ownership Interests - Epic Sciences
Honoraria - Development Dynamics SD, CA
Consulting or Advisory Role - Development Dynamics SD, CA
Research Funding - Epic Sciences
Travel, Accommodations, Expenses - Epic Sciences
 
Josee-Lyne Ethier
Honoraria - AstraZeneca; GlaxoSmithKline; Merck
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; Merck
 
Sara V. Soldera
Leadership - Bluelight Analytics (I); Bluezone Technologies (I); Centricity Research (I); Icentia (I); LMC Healthcare (I); Panthera Dental (I); PreciThera (I); Trutag Technologies (I)
Stock and Other Ownership Interests - Carebrook Technologies (I); LMC Healthcare (I)
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Exact Sciences; La Roche-Posay; Lilly; Merck; Novartis; Pfizer; Roche; Seagen